SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending following news of its merger with nuclear fusion company TAE Technologies, sparking fervent discussion. Supporters view this unexpected pivot into the energy sector as a visionary move with potential for significant growth, especially in powering AI infrastructure. Conversely, many skeptics express concerns about dilution and the highly speculative nature of commercial fusion, questioning the long-term viability and profitability of this ambitious venture.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing significant bullish momentum driven by a major $816 million prime contract award from the U.S. Space Force to develop and manufacture 18 missile defense satellites, solidifying its role alongside established defense primes. The community is actively discussing this as a transformative win, celebrating the company's expanding capabilities beyond launches as an end-to-end space provider, and viewing it as a strong validation for the burgeoning space sector as a whole. While many anticipate substantial future growth and a potential re-rating in valuation, some investors remain cautious about immediate profitability and the long-term cash requirements for ambitious projects like Neutron.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

Newegg Commerce is trending amidst significant insider buying, with a key investor's increasing stake fueling community discussions around an exceptionally tight share float. Investors are keenly focused on a potential short squeeze, citing high short interest and alleged market manipulation, while also noting recent strategic integrations with PayPal and SHEIN as positive developments for the company.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is drawing significant investor interest as its next-generation BlueBird 6 satellite prepares for launch, a pivotal moment anticipated to demonstrate its direct-to-smartphone connectivity capabilities globally. The community is actively discussing this critical launch and its potential impact, alongside broader enthusiasm for the space sector driven by recent defense initiatives like the 'Golden Dome' program.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

Flora Growth Corp. is trending due to its strategic pivot and rebranding as ZeroStack, now focused on a significant crypto treasury strategy involving 0G tokens for decentralized AI infrastructure. The community is actively discussing the perceived massive undervaluation, highlighting its substantial crypto holdings against a low market capitalization and strong short-squeeze potential. This hybrid cannabis and AI-blockchain play has generated significant buzz, with many anticipating a substantial surge.

A fun meme coin with no utility beyond spreading Christmas cheer. X is exploding with people changing their profile pictures to include a Santa Hat, we are taking advantage of the hype and launched the perfect token for it. Beyond that, there is no function. Just spreading joy this season. Elon Musk himself changed his profile picture. The coin is run by one of the biggest influencers on X No utility, run purely on hype and memes

SANTA HAT

SANTAHAT CRYPTO is gaining traction, driven by its festive meme appeal and speculative interest within the crypto community. Traders are actively discussing its potential for a significant upward move, with many hoping this holiday-themed token will "go to the moon." This widespread conversation highlights the speculative enthusiasm often seen around meme coins during seasonal periods.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending strongly following the launch of its token buyback program, fueled by substantial revenue from its Pyth PRO service, aimed at enhancing network value. Community discussion is further driven by the U.S. Department of Commerce's selection of Pyth to publish official economic data on-chain, a move seen as a major validation for decentralized real-world data infrastructure. Investors are actively debating its potential to become a dominant oracle solution within the crypto ecosystem.

TOSHI

TOSHI is trending as the recognized "Face of Base," driven by its strong association with Coinbase and recent exchange listings, which are enhancing its market visibility. The community is actively discussing its deeply oversold status, viewing current prices as a significant accumulation opportunity with many anticipating a substantial rebound. Despite wider market fluctuations, confidence remains high in TOSHI's evolving utility and long-term potential beyond its meme coin beginnings.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending with high volume and spirited debate, fueled by a recent "Overweight" analyst rating and strong anticipation of a significant NASA Lunar Terrain Vehicle (LTV) contract award. While bulls envision substantial upside and a short squeeze within the burgeoning space exploration sector, bears highlight past profitability challenges and recent insider stock sales as red flags. The community remains focused on the potential LTV catalyst to further propel its market trajectory.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Cytokinetics is actively trending following its FDA approval for MYQORZO (aficamten) for obstructive hypertrophic cardiomyopathy and strong MAPLE-HCM trial data showing superiority over standard-of-care. The community is debating the stock's price action post-approval, its differentiation from competitors like Camzyos, and persistent buyout speculation, often coupled with strong opinions on management's strategy and future sales potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Precigen (NASDAQ:PGEN) Trading 5.3% Higher - Here's What Happened

Precigen (NASDAQ:PGEN) Shares Up 5.3% - Should You Buy...

Diametric Capital LP Buys New Holdings in Precigen, Inc. $PGEN

Diametric Capital LP purchased a new position in shares of Precigen, Inc. (NASDAQ:PGEN - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and...

Patient Capital Management LLC Sells 1,103,560 Shares of Precigen, Inc. $PGEN

Patient Capital Management LLC trimmed its position in shares of Precigen, Inc. (NASDAQ:PGEN - Free Report) by 6.4% during the second quarter, according to the company in its most recent Form 13F...

Precigen, Inc. (NASDAQ:PGEN) Receives Average Rating of "Moderate Buy" from Brokerages

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six research firms that are currently covering the company, Marketbeat Ratings reports. One...

Precigen (NASDAQ:PGEN) Trading Down 4.9% - Here's Why

Precigen (NASDAQ:PGEN) Stock Price Down 4.9% - Should You Sell...

Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 942,832 Shares of Stock

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) Director Randal Kirk sold 942,832 shares of the business's stock in a transaction on Thursday, November 20th. The shares were sold at an average price...

Precigen (NASDAQ:PGEN) Director Sells 1,086,153 Shares

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) Director Randal Kirk sold 1,086,153 shares of the business's stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an...

Precigen (NASDAQ:PGEN) Director Sells $3,589,889.64 in Stock

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) Director Randal Kirk sold 937,308 shares of the company's stock in a transaction on Friday, November 21st. The shares were sold at an average price of...

Precigen (NASDAQ:PGEN) Stock Price Down 9% - Time to Sell?

Precigen (NASDAQ:PGEN) Shares Down 9% - Time to Sell...

Precigen (NASDAQ:PGEN) Announces Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Precigen (NASDAQ:PGEN - Get Free Report) released its quarterly earnings data on Thursday. The biotechnology company reported ($1.06) earnings per share for the quarter, missing analysts' consensus...

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Current Price	$4.32
Prev Close	$4.17
Open	$4.22
Dividend Yield	0.00%
50-Day Moving Average	$3.88
Beta	1.86
Avg. Volume	4.74M
PE Ratio	-2.98

52-Week High	$5.23
52-Week Low	$0.6916
Market Capitalization	$1.5B
EPS (Annual)	-$0.4715
Price to Book	35.24
Revenue Per Employee	$27,447.55
Enterprise Value/EBITDA	N/A

PGEN
Precigen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PGEN News

PGENPrecigen Inc